Navigation path

Pharmaceuticals - Union Register


Union Register of veterinary medicinal products


Product information

Invented name: Leucofeligen FeLV/RCP   
Auth. number : EU/2/09/097
Active substance : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AH - Live and inactivated viral vaccines
Chemical substance: QI06AH07 - live feline panleucopenia virus / parvovirus + live feline rhinotracheitis virus + live feline calicivirus + inactivated feline leukaemia virus
(See WHO ATCvet Index)
Indication: For active immunisation of cats from eight weeks of age against:

- feline calicivirosis to reduce clinical signs,
- feline viral rhinotracheitis to reduce clinical signs and viral excretion,
- feline panleucopenia to prevent leucopenia and to reduce clinical signs,
- feline leukaemia to prevent persistent viraemia and clinical signs of the related disease.

The onset of immunity has been demonstrated from:
- 3 weeks after the primary vaccination for the panleucopenia and leukaemia components,
- 4 weeks after the primary vaccination for the calicivirus and rhinotracheitis virus components.

After the primary vaccination course, the duration of immunity lasts for one year for all components.

Following a first booster vaccination one year after the primary vaccination course, a duration of immunity of 3 years has been demonstrated for the leukaemia component.
Marketing Authorisation Holder: Virbac
1ère Avenue - 2065 m - L.I.D., 06516 Carros CEDEX, France
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Union Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/06/2009 Centralised - Authorisation EMEA/V/C/143 (2009)5258 of 25/06/2009
3/01/2011 Centralised - Variation EMEA/V/C/143/IB/1
Updated with Decision(2011)5066 of 07/07/2011
11/07/2011 Centralised - Variation (2011)5066 of 7/07/2011
11/06/2014 Centralised - Renewal EMEA/V/C/143/R/3 (2014)3945 of 6/06/2014
11/12/2014 Centralised - Variation EMEA/V/C/143/WS/639
Updated with Decision(2015)8365 of 20/11/2015
24/11/2015 Centralised - Yearly update (2015)8365 of 20/11/2015
21/12/2016 Centralised - Variation EMEA/V/C/143/IG 724
Updated with Decision(2018)231 of 12/01/2018
16/01/2018 Centralised - Yearly update (2018)231 of 12/01/2018
14/08/2018 Centralised - 2-Monthly update EMEA/V/C/143/WS/1282/7 (2018)5536 of 9/08/2018
26/10/2018 Centralised - Variation EMEA/V/C/143/IG/984/9